Pathological complete response, long-term outcomes, and recurrence patterns in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Pathological complete response, long-term outcomes, and recurrence patterns in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy

Published:2022-11 Issue: Volume:176 Page:30-40
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kang Sora^ORCID,Lee So H.,Lee Hee J.,Jeong Hyehyun^ORCID,Jeong Jae H.,Kim Jeong E.^ORCID,Ahn Jin-Hee^ORCID,Jung Kyung H.^ORCID,Gong Gyungyub,Kim Hak H.,Lee Saebyeol^ORCID,Lee Jongwon,Kim Sung-Bae^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Molecular classification of breast cancer;Tsang;Adv Anat Pathol,2020

2. HER2 in breast cancer: a review and update;Krishnamurti;Adv Anat Pathol,2014

3. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update;Wolff;J Clin Oncol,2018

4. The latest research and development into the antibody–drug conjugate, [fam-] trastuzumab deruxtecan (DS-8201a), for HER2 cancer therapy;Nakada;Chem Pharm Bull,2019

5. Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer;Modi;N Engl J Med,2022

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of HER2-Low Breast Tumors among a Cohort of Colombian Women;Cancers;2024-09-12

2. Prognosis in HR-positive metastatic breast cancer with HER2-low versus HER2-zero treated with CDK4/6 inhibitor and endocrine therapy: a meta-analysis;Frontiers in Oncology;2024-08-29

3. HER2-Low Breast Cancer: Now and in the Future;Cancer Research and Treatment;2024-07-15

4. Development and validation of machine learning models for predicting HER2-zero and HER2-low breast cancers;British Journal of Radiology;2024-07-11

5. The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study;Breast Cancer Research and Treatment;2024-05-14